Cardiologist, Greensboro, NC
When his ambulatory cardiac monitoring methods fell short, Dr. Bensimhon knew there had to be a better way.
Then he found Zio.
Zio isn’t
just a monitor.
It’s a complete ambulatory cardiac monitoring solution, featuring patient-friendly monitors, actionable reports, and a convenient clinician portal.
With Zio, you’ll get trustworthy data,¹ a positive patient experience,² and ultimately, influence what matters most:
Improved clinical outcomes.²
Zio isn’t
just a monitor.
It’s a complete ambulatory cardiac monitoring solution, featuring patient-friendly monitors, actionable reports, and a convenient clinician portal.
With Zio, you’ll get trustworthy data,¹ a positive patient experience,² and ultimately, influence what matters most:
Improved clinical outcomes.²
The most
advanced AI in
cardiac monitoring.3,4,5,6
4 million+
patient records7
34 layer
deep neural
network
1 billion+ hours
of heart
rhythm data
High-quality, actionable data
helps you:
definitive diagnosis
time to treatment
patient access
How does the Zio service work?
- Data on file. iRhythm Technologies, 2021.
- Barrett et al., Comparison of 24-hour Holter Monitoring with 14-day Novel Adhesive Patch Electrocardiographic Monitoring. American Journal of Medicine, 2014.
- Over 4 million patient records, over 1 billion hours of heart rhythm data, 34 layer deep neural network. Data on file, iRhythm Technologies 2022.
- Hannun, AY. et al. Cardiologist-level arrhythmia detection and classification in ambulatory electrocardiograms using a deep neural network. Nature Medicine, 2019.
- FDA 510K clearance.
- Deep learned algorithm is only available in the United States.
- iRhythm Technologies, 2020. Form 10-K 2019. Retrieved from https://d18rn0p25nwr6d.cloudfront.net/CIK-0001388658/751cac69-c4c8-4eb4-b76a-b15b1c1b9327.pdf
- Case study data was gathered in partnership with the health system featured. The name and identifying details of the health system have been changed to protect the privacy of patients and practices. Healthcare System C. Source: Data on file. iRhythm Technologies. Diagnostic yield increased: 73.4% of patients received a definitive diagnosis vs. 20% with Holter monitoring.
- Healthcare System D, Partnering to improve processes and performance of a cardiovascular program: case study.
- Case study. New Mexico Heart Institute. Data on file at iRhythm 2018–2021. Analysis comparing Holter to Zio with no additional staff added. iRhythm Technologies, 2021.